期刊文献+

组蛋白去乙酰化酶抑制剂联合顺铂对宫颈癌细胞化疗增敏作用的研究 被引量:3

Sensitizing effect of SAHA combined with DDP on cervical cancer cells
下载PDF
导出
摘要 目的:通过检测组蛋白去乙酰化酶抑制剂(SAHA)联合顺铂(DDP)对宫颈癌SiHa细胞生长抑制和促凋亡结果,探讨SAHA对宫颈癌细胞化疗增敏的疗效及机制。方法:将SAHA 0.25、0.5、1、2、4、6μmol/L和DDP 1、2、4、6、8、10μg/mL分别组成单药组和不同SAHA+DDP联合用药组,另设不加药对照组。MTT法检测两种药物单用及联合用药对SiHa细胞的增殖抑制作用;通过流式细胞术(FCM)观察药物对细胞周期的影响;用AnnexinV-FITC标记药物作用后的细胞,了解其早期凋亡情况;镜检观察药物作用后细胞形态的变化。结果:SAHA有抑制癌细胞生长的作用,两药联合具有协同作用或相加作用(P<0.05);SAHA使细胞停滞在G1/G0期,与DDP联合作用后凋亡率增加,使细胞周期进一步阻滞在G1/G0期(P<0.05)。镜下可见对照组癌细胞生长旺盛,异型性高,SA-HA组与DDP组则可见细胞缩小变形,胞膜皱缩,贴壁不良,肿瘤细胞大量坏死,联用组尤为明显。结论:SAHA联合DDP可以抑制细胞增殖,停滞细胞周期,促进细胞凋亡,二者联合有协同作用。 Objective:The purpose of this study is to explore the effect of SAHA combined with DDP on cervical cancer cell line SiHa.Methods:SiHa cells were treated with different concentrations of SAHA(0.25,0.5,1,2,4 and 6μmol/L) or DDP(1,2,4,6,8 and 10μg/mL) repectively(SAHA or DDP group),and SAHA+DDP(SAHA +DDP group).The untreated cells were taken as control group.The effect of SAHA combined with DDP on proliferation of SiHa cells was analyzed with MTT.Cell cycle distribution was detected by flow cytometry.Early apoptotic cells were stained with Annexin V-FITC.The morphological changes of tumor cells were observed by inverted phase contrast microscope.Results:The results showed that SAHA was capable of inhibiting SiHa cells growth and promoting cell differentiation.Meanwhile there was a synergistic effect when combined with DDP(P0.05).SAHA could induce cell apoptosis and arrested cell at G1/G0 phase.When combined with DDP,SAHA induced more severe apoptosis and arrested cell at G1/G0 phase.Microscopy showed that SiHa cells had a marked proliferation and a high cellular atypia in the control group.But the tumor cells in the treatment group were significantly decreased.A great amount of cell necrosis was observed in the DDP group and the SAHA group,especially in the SAHA+DDP group(P0.05).Conclusion:SAHA can induce apoptosis and differentiation of SiHa cells and has a synergistic effect with DDP.
出处 《现代妇产科进展》 CSCD 北大核心 2011年第2期105-108,112,共5页 Progress in Obstetrics and Gynecology
关键词 组蛋白去乙酰化酶抑制剂 顺铂 SIHA 增敏作用 SAHA DDP SiHa Sensitizing effect
  • 相关文献

参考文献11

  • 1顾晓梅,张玉泉.宫颈癌的流行病学高危因素研究进展[J].中国妇幼保健,2007,22(35):5073-5075. 被引量:35
  • 2Tony T, Laura C, Kamille P, et ah The histone deacetylase inhibitor PXD10I synergises with 5-fluorouracil to inhibit tuinour cell growth in vitro and in vivo [ J ]. AACR,2005, (4) :1202-1203.
  • 3Hrzenjak A, Kremser ML, Strohmeier B, et al. SAHA induces caspase-independent,autophagic cell death of endometrial stromal sarcoma cells by intluencing the mTOll pathway[J]. J Patho1,2008 ,216 :495-504.
  • 4Owens J. 2006 drug approvals : finding the niche [ J ]. Nat Rev Drug Discov,2007,6(2) :99-101.
  • 5Kelly WK, Marks PA. Drug insight: Histone deacetylase inhibitors-developmenl of the new targeled anticaneer a- gent suberoylanilide hydroxamie ae, id [ J ]. Nat Clin Praet Oneol ,2005,2 (3) : 150-157.
  • 6Whang YM, Choi E J, Seo ,JH, el al. Hyperacetylation en- ham.es the growth-inhilbitory effeet of all-lrans relinoie acid by lhe resloration of relinolc acid reeeplor bela ex- pression in head and neck squamous carcinonia (HNSCC) cells [ J ]. Cancer Chemother Pharmacol,2005, 56( 5 ) :543-555.
  • 7戴体俊.合并用药的定量分析[J].中国药理学通报,1998,14(5):479-480. 被引量:136
  • 8Fadi B, Andres O, Soriano G, et al. Phase I study of epige- netic modulatinn with 5-azacytidine and valproic acid in patients with advanced cancers [ J ]. Clin Cancer Res, 2008,14 (19) :6296-6301.
  • 9Candelaria M, Gallardo-Rincon D, Arce C, et al. Phase II study of epigenetie therapy with hydralazin and magnesium valproate to overcome chemotherapy resistance in refraetory solid tumors [ J ]. Ann Oneol,2007,18 (9) : 1529-1538.
  • 10Cha TL, Chuang M J, Wu ST,et al. Degradation of aurora A and B kinases by the histone deacelylase inhibitor LBH589 induces G2-M arrest and apoplosis of renal cancer cells[ J ]. Clin Cancer Res ,2009,15 (3) :840-850.

二级参考文献30

  • 1楼洪坤,吴荣献,傅一穷,吴志平,何登全.硒与子宫颈癌关系的初步探讨[J].中华肿瘤杂志,1995,17(2):112-114. 被引量:6
  • 2乐杰主编.妇产科学.第5版,北京:人民卫生出版社,2003:416~420
  • 3Levi F, Luchini F, Negri E et al. Cervical cancer mortality in young women in Europe. Eur Jcancer, 2000, 36 ( 17 ) : 2266
  • 4Ziegler R, Wesintein S, Fears T. Nutritional and genetic inefficiencies in one - carbon mtabolism and cervical cancerrisk. The Journal of Nutrition , 2002, 132 (8): 234
  • 5Schlect N, Kulaga S, Robitaille J et al. Persistem Human pillomavirus infection as a predictor of cervicalintraepithelial. JAMA, 2001. 286 (24) : 3106
  • 6Chichareon S, Herrero R, Munoz N et al. Risk factors for cervical cancer in Thailand : A case - control study . Journal ofthe National cancer Institute, 1998, 90 (1) : 50
  • 7Dillner J, Lehtinen M, Bjorge T et al. Prospective seroepidemiologic study of human papillomavirus infection as a fiskfactor for invasive cervical cancer. Journal of the National Cancer institute. 1997, 89 (17) : 1293
  • 8Munoz N, Bosch F, Sanjose S et al. Epidemiologic classification of human papillomavims types associated withcervical cancer. The New England Journal of Medicine, 2003, 348 (6): 518
  • 9Castellsague X, Menendez C, Loscertales Met al. Human papillomavirus genotypes in rural Mozambique. TheLancet, 2001, 358 (9291) : 1429
  • 10Ferrera A, Olivo A, Alaez C et al. HLA DQA 1 and DQB 1 loci in Honduran women with cervical dysplasia and invasivecervical carcinoma and their relationship to human papillomavirus infection. Human Biology. 1999, 71 (3): 367

共引文献169

同被引文献36

  • 1黄顺玲,王晓春,陈卫群.宫颈组织临床样本HPV16-E6的阳性率检测[J].中国现代医学杂志,2006,16(24):3720-3722. 被引量:6
  • 2Smith JS, Lindsay L, HootsB, et al. Human papillomavirus type distribution in invasive cervical cancer and high-grade cervical |e- sions: a meta-analysis update [ J ]. Int J Cancer, 2007,121 ( 3 ) : 621-632.
  • 3Jin KL, Pak JH, Park JY, et al. Expression profile of histone deacetylases 1,2 and 3 in ovarian cancer tissues [ J ]. J Gynecol On- col, 2008,19(3) :185-190.
  • 4Huang BH, Laban M, Leung CH, et al. Inhibition of histone deacetylase 2 increases apoptosis and p21Cipl/WAF1 expression, independent of histone deacetylase 1 [ J ]. Cell Death Differ, 2005, 12(4) :395-404.
  • 5Shin MK, Balsitis S, Brake T, et al. Human papillomavirus E7 on- coprotein overrides the tumor suppressor activity of p21Cipl in cervi- cal carcinogenesis[ J ]. Cancer Res, 2009,15,69 (14) :5656-5663.
  • 6Cuzick J, Arbyn M, Sankaranarayanan R, et al. Overview of human papillomavirus-based and other novel opitions for cervical cencer screening in developed and developing countries[J]. Vaccine, 2008, 26 (52) : 6743-6744.
  • 7Nyati MK, Symon Z, Kievit E, et al. The potential ot 5-fluorocytosine/cytosine deaminase enzyme Prodrug gene therapy in an intrahepatic colon cancer model[J]. Gene Ther, 2002, 9 (13) : 844-849.
  • 8徐冰河.乳腺癌[M].北京:北京大学医学出版社,2006:15-21.
  • 9Lee DY, Hayes JJ, Pruss D, et al. A positive role for histone acetylation in transcription factor access to nucleosomal DNA[J]. Cell, 1993, 72 (1) .. 73-84.
  • 10Kim MS, Blake M, Baek JH, et al. Inhibition of histone deacetylase increases cytotoxicity to anticancer drugs targeting DNA[J]. CancerRes, 2003, 63 (21) : 7291-7 300.

引证文献3

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部